57 results on '"Suh, Chang Hee"'
Search Results
2. Association between CCR2 and CCL2 expression and NET stimulation in adult-onset Still’s disease
3. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study
4. Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
5. Publisher Correction: Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease
6. Correlations between salivary gland scintigraphy and histopathologic data of salivary glands in patients with primary Sjogren’s syndrome
7. Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease
8. Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry
9. Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature
10. Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study
11. Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease
12. A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
13. Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus
14. Associated clinical factors for serious infections in patients with systemic lupus erythematosus
15. Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
16. Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study
17. Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
18. Clinical characteristics and role of whole-body bone scan in multifocal osteonecrosis
19. Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review
20. Effect of fenofibrate on uric acid level in patients with gout
21. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still’s disease
22. Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever
23. Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus
24. Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial
25. Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis
26. Elevated circulating levels of the interferon-γ–induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still’s disease
27. Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab
28. Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis
29. Elevated high-mobility group B1 levels in active adult-onset Still’s disease associated with systemic score and skin rash
30. Hyponatremia in patients with systemic lupus erythematosus
31. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry
32. An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population
33. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still’s disease
34. Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines
35. Optimization of the hot workability for an extrude AZ80 Mg alloy using the processing map and Kriging meta-model
36. Role of bone scan in the assessment of polymyositis/dermatomyositis
37. Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still’s disease
38. Efficacy and safety of PG201 (Layla®) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study
39. Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans
40. Serum Growth Arrest-Specific Protein 6 Levels are a Reliable Biomarker of Disease Activity in Systemic Lupus Erythematosus
41. Value of multidetector computed tomography for the radiologic grading of sacroiliitis in ankylosing spondylitis
42. Effect of cooling rate during hot stamping on low cyclic fatigue of boron steel sheet
43. Therapeutic responses and prognosis in Korean adult-onset Still’s disease
44. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy
45. Effect of welding heat input on fatigue life of quenched boron steel and FB steel lap joint
46. Therapeutic responses and prognosis in adult-onset Still’s disease
47. Effects of thickness and surface roughness on mechanical properties of aluminum sheets
48. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus
49. TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
50. SLE developed in a preadolescent child with Klinefelter syndrome who had no detectable sex hormone
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.